Vitamin C deficiency increases basal exploratory activity but decreases scopolamine-induced activity in APP/PSEN1 transgenic mice

Pharmacology Biochemistry and Behavior

Volumn 94, Issue 4, 2010, Pages 543-552

  Harrison, F E ^a   May, J M ^a   McDonald, M P ^b  

^a VANDERBILT UNIVERSITY   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

amyloid; Alzheimer's disease; APP PSEN1; Cholinergic; Cognition; Locomotor activity, oxidative stress; Vitamin C

Indexed keywords

AMYLOID PRECURSOR PROTEIN; ASCORBIC ACID; PRESENILIN 1; SCOPOLAMINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASCORBIC ACID DEFICIENCY; CHOLINERGIC SYSTEM; CONTROLLED STUDY; EXPLORATORY BEHAVIOR; HABITUATION; LEARNING DISORDER; MAZE TEST; MOUSE; NEUROPATHOLOGY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; TRANSGENIC MOUSE;

AMYLOID; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; ASCORBIC ACID; ASCORBIC ACID DEFICIENCY; BRAIN; EXPLORATORY BEHAVIOR; FEMALE; L-GULONOLACTONE OXIDASE; LIPID PEROXIDATION; MALE; MAZE LEARNING; MICE; MICE, TRANSGENIC; OXIDATIVE STRESS; PRESENILIN-1; SURVIVAL RATE;

GULO; MUS; MUS MUSCULUS;

EID: 74249088881     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2009.11.009     Document Type: Article

References (85)

1. Alzheimer's Association. Alzheimer's disease facts and figures. Alzheimers Dement 4 (2008) 110-133
2. Arzi A., Hemmati A.A., and Razian A. Effect of vitamins C and E on cognitive function in mouse. Pharmacol Res 49 (2004) 249-252
3. Bazalakova M.H., Wright J., Schneble E.J., McDonald M.P., Heilman C.J., Levey A.I., et al. Deficits in acetylcholine homeostasis, receptors and behaviors in choline transporter heterozygous mice. Genes Brain Behav 6 (2007) 411-424
4. Bemeur C., Ste-Marie L., Desjardins P., Vachon L., Butterworth R.F., Hazell A.S., et al. Dehydroascorbic acid normalizes several markers of oxidative stress and inflammation in acute hyperglycemic focal cerebral ischemia in the rat. Neurochem Int 46 (2005) 399-407
5. Bernardo A., Harrison F.E., McCord M., Zhao J., Bruchey A., Davies S.S., et al. Elimination of GD3 synthase improves memory and reduces amyloid-beta plaque load in transgenic mice. Neurobiol Aging (2008)
6. Bernardo A., McCord M., Troen A.M., Allison J.D., and McDonald M.P. Impaired spatial memory in APP-overexpressing mice on a homocysteinemia-inducing diet. Neurobiol Aging 28 (2007) 1195-1205
7. Bielski B.H., Allen A.O., and Schwarz H.A. Mechanisms of disproportionation of ascorbate radicals. J Am Chem Soc 103 (1981) 3516-3518
8. Bowman G.L., Dodge H., Frei B., Calabrese C., Oken B.S., Kaye J.A., et al. Ascorbic acid and rates of cognitive decline in Alzheimer's disease. J Alzheimers Dis 16 (2009) 93-98
9. Butterfield D.A., Drake J., Pocernich C., and Castegna A. Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide. Trends Mol Med 7 (2001) 548-554
10. Caballero B., Vega-Naredo I., Sierra V., Huidobro-Fernandez C., Soria-Valles C., De Gonzalo-Calvo D., et al. Melatonin alters cell death processes in response to age-related oxidative stress in the brain of senescence-accelerated mice. J Pineal Res 46 (2009) 106-114
11. Castellani R.J., Lee H.G., Zhu X., Nunomura A., Perry G., and Smith M.A. Neuropathology of Alzheimer disease: pathognomonic but not pathogenic. Acta Neuropathol 111 (2006) 503-509
12. Charlton K.E., Rabinowitz T.L., Geffen L.N., and Dhansay M.A. Lowered plasma vitamin C, but not vitamin E, concentrations in dementia patients. J Nutr Health Aging 8 (2004) 99-107
13. Cleary J.P., Walsh D.M., Hofmeister J.J., Shankar G.M., Kuskowski M.A., Selkoe D.J., et al. Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function. Nat Neurosci 8 (2005) 79-84
14. de Angelis L., and Furlan C. The effects of ascorbic acid and oxiracetam on scopolamine-induced amnesia in a habituation test in aged mice. Neurobiol Learn Mem 64 (1995) 119-124
15. Deana R., Bharaj B.S., Verjee Z.H., and Galzigna L. Changes relevant to catecholamine metabolism in liver and brain of ascorbic acid deficient guinea-pigs. International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung 45 (1975) 175-182
16. Dhariwal K.R., Hartzell W.O., and Levine M. Ascorbic acid and dehydroascorbic acid measurements in human plasma and serum. Am J Clin Nutr 54 (1991) 712-716
17. Dhingra D., Parle M., and Kulkarni S.K. Comparative brain cholinesterase-inhibiting activity of Glycyrrhiza glabra, Myristica fragrans, ascorbic acid, and metrifonate in mice. J Med Food 9 (2006) 281-283
18. Ding Y., Qiao A., Wang Z., Goodwin J.S., Lee E.S., Block M.L., et al. Retinoic acid attenuates beta-amyloid deposition and rescues memory deficits in an Alzheimer's disease transgenic mouse model. J Neurosci 28 (2008) 11622-11634
19. Douglas C.L., Baghdoyan H.A., and Lydic R. M2 muscarinic autoreceptors modulate acetylcholine release in prefrontal cortex of C57BL/6 J mouse. J Pharmacol Exp Ther 299 (2001) 960-966
20. Ebbinghaus H. Memory: a contribution to experimental psychology (1885), Teachers College, New York Translated by Henry A. Ruger & Clara E. Bussenius (1913)
21. Engelhart M.J., Geerlings M.I., Ruitenberg A., van Swieten J.C., Hofman A., Witteman J.C., et al. Dietary intake of antioxidants and risk of Alzheimer disease. Jama 287 (2002) 3223-3229
22. Feng Z., Chang Y., Cheng Y., Zhang B.L., Qu Z.W., Qin C., et al. Melatonin alleviates behavioral deficits associated with apoptosis and cholinergic system dysfunction in the APP 695 transgenic mouse model of Alzheimer's disease. J Pineal Res 37 (2004) 129-136
23. Fink H., and Morgenstern R. Scopolamine-induced hypermotility in rats is mediated via a dopaminergic system. Acta Biol Med Ger 39 (1980) 903-910
24. Gallagher M., Burwell R., and Burchinal M. Severity of spatial learning impairment in aging: development of a learning index for performance in the Morris water maze. Behav Neurosci 107 (1993) 618-626
25. Garcia-Alloza M., Robbins E.M., Zhang-Nunes S.X., Purcell S.M., Betensky R.A., Raju S., et al. Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease. Neurobiol Dis 24 (2006) 516-524
26. Gordon M.N., Holcomb L.A., Jantzen P.T., DiCarlo G., Wilcock D., Boyett K.W., et al. Time course of the development of Alzheimer-like pathology in the doubly transgenic PS1 + APP mouse. Exp Neurol 173 (2002) 183-195
27. Goto Y., Niidome T., Hongo H., Akaike A., Kihara T., and Sugimoto H. Impaired muscarinic regulation of excitatory synaptic transmission in the APPswe/PS1dE9 mouse model of Alzheimer's disease. Eur J Pharmacol 583 (2008) 84-91
28. Gray S.L., Anderson M.L., Crane P.K., Breitner J.C., McCormick W., Bowen J.D., et al. Antioxidant vitamin supplement use and risk of dementia or Alzheimer's disease in older adults. J Am Geriatr Soc 56 (2008) 291-295
29. Hampl J.S., Taylor C.A., and Johnston C.S. Vitamin C deficiency and depletion in the United States: the Third National Health and Nutrition Examination Survey, 1988 to 1994. Am J Public Health 94 (2004) 870-875
30. Harrison F.E., and May J.M. Vitamin C function in the brain: vital role of the ascorbate transporter SVCT2. Free Radic Biol Med (2009)
31. Harrison F.E., Reiserer R.S., Tomarken A.J., and McDonald M.P. Spatial and nonspatial escape strategies in the Barnes maze. Learning & memory vol. 13 (2006) 809-819 Cold Spring Harbor, N.Y
32. Harrison F.E., Yu S.S., Van Den Bossche K.L., Li L., May J.M., and McDonald M.P. Elevated oxidative stress and sensorimotor deficits but normal cognition in mice that cannot synthesize ascorbic acid. J Neurochem 106 (2008) 1198-1208
33. Harrison F.E., Hosseini A.H., Dawes S.M., Weaver S., and May J.M. Ascorbic acid attenuates scopolamine-induced spatial learning deficits in the water maze. Behav Brain Res 205 2 (2009) 550-558
34. Harrison F.E., Hosseini A.H., McDonald M.P., and May J.M. Vitamin C reduces spatial learning deficits in middle-aged and very old APP/PSEN1 transgenic and wild-type mice. Pharmacol Biochem Behav 93 (2009) 443-450
35. Harrison F.E., Allard J., Bixler R., Usoh C., Li L., and May J. M., & McDonald, M. P. Antioxidants and cognitive training interact to affect oxidative stress and memory in APP/PSEN1 mice. Nutr Neurosci 12 (2009) 203-218
36. Hartman R.E., Shah A., Fagan A.M., Schwetye K.E., Parsadanian M., Schulman R.N., et al. Pomegranate juice decreases amyloid load and improves behavior in a mouse model of Alzheimer's disease. Neurobiol Dis 24 (2006) 506-515
37. Hoehn S.K., and Kanfer J.N. Effects of chronic ascorbic acid deficiency on guinea pig lysosomal hydrolase activities. J Nutr 110 (1980) 2085-2094
38. Holmes A., Wrenn C.C., Harris A.P., Thayer K.E., and Crawley J.N. Behavioral profiles of inbred strains on novel olfactory, spatial and emotional tests for reference memory in mice. Genes Brain Behav 1 (2002) 55-69
39. Johnston C.S., Solomon R.E., and Corte C. Vitamin C status of a campus population: college students get a C minus. J Am Coll Health 46 (1998) 209-213
40. Johnston C.S., and Thompson L.L. Vitamin C status of an outpatient population. J Am Coll Nutr 17 (1998) 366-370
41. Kaufmann P., Wiens W., Dirks M., and Krehbiel D. Changes in social behavior and brain catecholamines during the development of ascorbate deficiency in guinea pigs. Behav Processes 13 (1986) 13-28
42. Kawarabayashi T., Younkin L.H., Saido T.C., Shoji M., Ashe K.H., and Younkin S.G. Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease. J Neurosci 21 (2001) 372-381
43. Lalonde R., Kim H.D., and Fukuchi K. Exploratory activity, anxiety, and motor coordination in bigenic APPswe + PS1/DeltaE9 mice. Neurosci Lett 369 (2004) 156-161
44. Lalonde R., Kim H.D., Maxwell J.A., and Fukuchi K. Exploratory activity and spatial learning in 12-month-old APP(695)SWE/co + PS1/DeltaE9 mice with amyloid plaques. Neurosci Lett 390 (2005) 87-92
45. Laurin D., Masaki K.H., Foley D.J., White L.R., and Launer L.J. Midlife dietary intake of antioxidants and risk of late-life incident dementia: the Honolulu-Asia Aging study. Am J Epidemiol 159 (2004) 959-967
46. Lim G.P., Chu T., Yang F., Beech W., Frautschy S.A., and Cole G.M. The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J Neurosci 21 (2001) 8370-8377
47. Luchsinger J.A., Tang M.X., Shea S., and Mayeux R. Antioxidant vitamin intake and risk of Alzheimer disease. Arch Neurol 60 (2003) 203-208
48. Machova E., Jakubik J., Michal P., Oksman M., Iivonen H., Tanila H., et al. Impairment of muscarinic transmission in transgenic APPswe/PS1dE9 mice. Neurobiol Aging 29 (2008) 368-378
49. Maeda N., Hagihara H., Nakata Y., Hiller S., Wilder J., and Reddick R. Aortic wall damage in mice unable to synthesize ascorbic acid. Proc Natl Acad Sci U S A 97 (2000) 841-846
50. Manelli A.M., and Puttfarcken P.S. Beta-amyloid-induced toxicity in rat hippocampal cells: in vitro evidence for the involvement of free radicals. Brain Res Bull 38 (1995) 569-576
51. Mark R.J., Blanc E.M., and Mattson M.P. Amyloid beta-peptide and oxidative cellular injury in Alzheimer's disease. Mol Neurobiol 12 (1996) 211-224
52. Mathur A., Shandarin A., LaViolette S.R., Parker J., and Yeomans J.S. Locomotion and stereotypy induced by scopolamine: contributions of muscarinic receptors near the pedunculopontine tegmental nucleus. Brain Res 775 (1997) 144-155
53. Mattson M.P. Existing data suggest that Alzheimer's disease is preventable. Ann N Y Acad Sci 924 (2000) 153-159
54. May J.M., Qu Z.C., and Mendiratta S. Protection and recycling of alpha-tocopherol in human erythrocytes by intracellular ascorbic acid. Arch Biochem Biophys 349 (1998) 281-289
55. McDonald M.P., Dahl E.E., Overmier J.B., Mantyh P., and Cleary J. Effects of an exogenous beta-amyloid peptide on retention for spatial learning. Behavioral Neural Biol 62 (1994) 60-67
56. McDonald M.P., Overmier J.B., Bandyopadhyay S., Babcock D., and Cleary J. Reversal of beta-amyloid-induced retention deficit after exposure to training and state cues. Neurobiol Learn Mem 65 (1996) 35-47
57. McDonald M.P., Wong R., Goldstein G., Weintraub B., Cheng S.Y., and Crawley J.N. Hyperactivity and learning deficits in transgenic mice bearing a human mutant thyroid hormone beta1 receptor gene. Learning & Memory vol. 5 (1998) 289-301 Cold Spring Harbor, N.Y
58. Minamizono A., Tomi M., and Hosoya K. Inhibition of dehydroascorbic acid transport across the rat blood-retinal and -brain barriers in experimental diabetes. Biol Pharm Bull 29 (2006) 2148-2150
59. Miyakawa T., Yamada M., Duttaroy A., and Wess J. Hyperactivity and intact hippocampus-dependent learning in mice lacking the M1 muscarinic acetylcholine receptor. J Neurosci 21 (2001) 5239-5250
60. Miyakawa T., Yared E., Pak J.H., Huang F.L., Huang K.P., and Crawley J.N. Neurogranin null mutant mice display performance deficits on spatial learning tasks with anxiety related components. Hippocampus 11 (2001) 763-775
61. Morris M.C., Beckett L.A., Scherr P.A., Hebert L.E., Bennett D.A., Field T.S., et al. Vitamin E and vitamin C supplement use and risk of incident Alzheimer disease. Alzheimer Dis Assoc Disord 12 (1998) 121-126
62. Morris M.C., Evans D.A., Bienias J.L., Tangney C.C., Bennett D.A., Aggarwal N., et al. Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study. JAMA 287 (2002) 3230-3237
63. Nunomura A., Moreira P.I., Lee H.G., Zhu X., Castellani R.J., Smith M.A., et al. Neuronal death and survival under oxidative stress in Alzheimer and Parkinson diseases. CNS & neurological disorders drug targets 6 (2007) 411-423
64. O'Neill R.D., and Fillenz M. Circadian changes in extracellular ascorbate in rat cortex, accumbens, striatum and hippocampus: correlations with motor activity. Neurosci Lett 60 (1985) 331-336
65. Pachla L.A., and Kissinger P.T. Analysis of ascorbic acid by liquid chromatography with amperometric detection. Methods Enzymol 62 (1979) 15-24
66. Pappolla M.A., Chyan Y.J., Omar R.A., Hsiao K., Perry G., Smith M.A., et al. Evidence of oxidative stress and in vivo neurotoxicity of beta-amyloid in a transgenic mouse model of Alzheimer's disease: a chronic oxidative paradigm for testing antioxidant therapies in vivo. Am J Pathol 152 (1998) 871-877
67. Paraskevas G.P., Kapaki E., Libitaki G., Zournas C., Segditsa I., and Papageorgiou C. Ascorbate in healthy subjects, amyotrophic lateral sclerosis and Alzheimer's disease. Acta Neurol Scand 96 (1997) 88-90
68. Parle M., and Dhingra D. Ascorbic acid: a promising memory-enhancer in mice. J Pharmacol Sci 93 (2003) 129-135
69. Parsons K.K., Maeda N., Yamauchi M., Banes A.J., and Koller B.H. Ascorbic acid-independent synthesis of collagen in mice. Am J Physiol 290 (2006) E1131-E1139
70. Perluigi M., Joshi G., Sultana R., Calabrese V., De Marco C., Coccia R., et al. In vivo protective effects of ferulic acid ethyl ester against amyloid-beta peptide 1-42-induced oxidative stress. J Neurosci Res 84 (2006) 418-426
71. Pierce R.C., and Rebec G.V. Stimulation of both D1 and D2 dopamine receptors increases behavioral activation and ascorbate release in the neostriatum of freely moving rats. Eur J Pharmacol 191 (1990) 295-302
72. Platel A., and Porsolt R.D. Habituation of exploratory activity in mice: a screening test for memory enhancing drugs. Psychopharmacology 78 (1982) 346-352
73. Quinn J.F., Bussiere J.R., Hammond R.S., Montine T.J., Henson E., Jones R.E., et al. Chronic dietary alpha-lipoic acid reduces deficits in hippocampal memory of aged Tg2576 mice. Neurobiol Aging 28 (2007) 213-225
74. Reiserer R.S., Harrison F.E., Syverud D.C., and McDonald M.P. Impaired spatial learning in the APPSwe + PSEN1DeltaE9 bigenic mouse model of Alzheimer's disease. Genes Brain Behav 6 (2007) 54-65
75. Resende R., Ferreiro E., Pereira C., and Resende de Oliveira C. Neurotoxic effect of oligomeric and fibrillar species of amyloid-beta peptide 1-42: involvement of endoplasmic reticulum calcium release in oligomer-induced cell death. Neuroscience 155 3 (2008) 725-737
76. Riviere S., Birlouez-Aragon I., Nourhashemi F., and Vellas B. Low plasma vitamin C in Alzheimer patients despite an adequate diet. Int J Geriatr Psychiatry 13 (1998) 749-754
77. Saner A., Weiser H., Hornig D., Da Prada M., and Pletscher A. Cerebral monoamine metabolism in guinea-pigs with ascorbic acid deficiency. J Pharm Pharmacol 27 (1975) 896-902
78. Siesser W.B., Zhao J., Miller L.R., Cheng S.Y., and McDonald M.P. Transgenic mice expressing a human mutant beta1 thyroid receptor are hyperactive, impulsive, and inattentive. Genes Brain Behav 5 (2006) 282-297
79. Sipos M.L., Burchnell V., and Galbicka G. Dose-response curves and time-course effects of selected anticholinergics on locomotor activity in rats. Psychopharmacology 147 (1999) 250-256
80. Stackman R.W., Eckenstein F., Frei B., Kulhanek D., Nowlin J., and Quinn J.F. Prevention of age-related spatial memory deficits in a transgenic mouse model of Alzheimer's disease by chronic Ginkgo biloba treatment. Exp Neurol 184 (2003) 510-520
81. Sung S., Yao Y., Uryu K., Yang H., Lee V.M., Trojanowski J.Q., et al. Early vitamin E supplementation in young but not aged mice reduces Abeta levels and amyloid deposition in a transgenic model of Alzheimer's disease. Faseb J 18 (2004) 323-325
82. Sweeney W.A., Luedtke J., McDonald M.P., and Overmier J.B. Intrahippocampal injections of exogenous beta-amyloid induce postdelay errors in an eight-arm radial maze. Neurobiol Learn Mem 68 (1997) 97-101
83. Tamagno E., Guglielmotto M., Aragno M., Borghi R., Autelli R., Giliberto L., et al. Oxidative stress activates a positive feedback between the gamma- and beta-secretase cleavages of the beta-amyloid precursor protein. J Neurochem 104 (2008) 683-695
84. Uberti D., Bianchi I., Olivari L., Ferrari-Toninelli G., Canonico P., and Memo M. Pramipexole prevents neurotoxicity induced by oligomers of beta-amyloid. Eur J Pharmacol 569 (2007) 194-196
85. Yang X., Yang Y., Li G., Wang J., and Yang E.S. Coenzyme Q10 attenuates beta-amyloid pathology in the aged transgenic mice with Alzheimer presenilin 1 mutation. J Mol Neurosci 34 (2008) 165-171